New Zealand markets closed

Thermo Fisher Scientific Inc. (TMO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
541.52-5.73 (-1.05%)
At close: 04:00PM EDT
575.00 +33.48 (+6.18%)
After hours: 07:44PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 206.71B
Enterprise value 233.55B
Trailing P/E 35.05
Forward P/E 25.00
PEG ratio (5-yr expected) 2.69
Price/sales (ttm)4.90
Price/book (mrq)4.42
Enterprise value/revenue 5.45
Enterprise value/EBITDA 21.08

Trading information

Stock price history

Beta (5Y monthly) 0.80
52-week change 3-5.28%
S&P500 52-week change 321.23%
52-week high 3603.82
52-week low 3415.60
50-day moving average 3570.83
200-day moving average 3528.67

Share statistics

Avg vol (3-month) 31.44M
Avg vol (10-day) 31.27M
Shares outstanding 5381.71M
Implied shares outstanding 6381.71M
Float 8380.42M
% held by insiders 10.18%
% held by institutions 192.22%
Shares short (28 Mar 2024) 42.58M
Short ratio (28 Mar 2024) 41.8
Short % of float (28 Mar 2024) 40.68%
Short % of shares outstanding (28 Mar 2024) 40.68%
Shares short (prior month 29 Feb 2024) 42.94M

Dividends & splits

Forward annual dividend rate 41.56
Forward annual dividend yield 40.29%
Trailing annual dividend rate 31.40
Trailing annual dividend yield 30.26%
5-year average dividend yield 40.22
Payout ratio 49.06%
Dividend date 315 Apr 2024
Ex-dividend date 414 Mar 2024
Last split factor 23:2
Last split date 306 Jun 1996

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 13.99%
Operating margin (ttm)18.66%

Management effectiveness

Return on assets (ttm)4.72%
Return on equity (ttm)13.09%

Income statement

Revenue (ttm)42.86B
Revenue per share (ttm)111.03
Quarterly revenue growth (yoy)-4.90%
Gross profit (ttm)N/A
EBITDA 10.8B
Net income avi to common (ttm)5.99B
Diluted EPS (ttm)15.43
Quarterly earnings growth (yoy)3.40%

Balance sheet

Total cash (mrq)8.08B
Total cash per share (mrq)21.18
Total debt (mrq)36.71B
Total debt/equity (mrq)78.37%
Current ratio (mrq)1.75
Book value per share (mrq)120.87

Cash flow statement

Operating cash flow (ttm)8.41B
Levered free cash flow (ttm)5.14B